| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
|
J Acquir Immune Defic Syndr
|
2007
|
3.38
|
|
2
|
Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.
|
Kidney Int
|
2011
|
2.28
|
|
3
|
Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
|
AIDS
|
2008
|
2.01
|
|
4
|
Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort.
|
AIDS Patient Care STDS
|
2007
|
1.55
|
|
5
|
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients.
|
Antimicrob Agents Chemother
|
2002
|
1.54
|
|
6
|
Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?
|
AIDS
|
2002
|
1.50
|
|
7
|
Hepatitis B vaccination in HIV-infected patients: a survey of physicians and patients participating in the Aquitaine cohort.
|
Gastroenterol Clin Biol
|
2006
|
1.42
|
|
8
|
Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.
|
Ann Med
|
2002
|
1.17
|
|
9
|
Introduction of SARS in France, March-April, 2003.
|
Emerg Infect Dis
|
2004
|
1.10
|
|
10
|
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens.
|
J Antimicrob Chemother
|
2010
|
1.08
|
|
11
|
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
|
Clin Infect Dis
|
2004
|
1.03
|
|
12
|
Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.
|
Clin Infect Dis
|
2005
|
1.03
|
|
13
|
Association between psoas abscess and prosthetic hip infection: a case-control study.
|
Acta Orthop
|
2009
|
1.01
|
|
14
|
Predictive value of provirus load and DNA human immunodeficiency virus genotype for successful abacavir-based simplified therapy.
|
J Infect Dis
|
2002
|
1.00
|
|
15
|
Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.
|
J Acquir Immune Defic Syndr
|
2009
|
1.00
|
|
16
|
Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort.
|
J Infect Dis
|
2012
|
0.96
|
|
17
|
Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004.
|
AIDS
|
2005
|
0.94
|
|
18
|
Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.
|
PLoS One
|
2010
|
0.93
|
|
19
|
Infectious Diseases Society of America guidelines for the diagnosis and management of prosthetic joint infection: what is the correct duration of antibiotic treatment?
|
Clin Infect Dis
|
2013
|
0.91
|
|
20
|
Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.
|
J Acquir Immune Defic Syndr
|
2007
|
0.90
|
|
21
|
Candida prosthetic infections: case series and literature review.
|
Scand J Infect Dis
|
2010
|
0.89
|
|
22
|
Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.
|
Gastroenterol Clin Biol
|
2007
|
0.87
|
|
23
|
Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
|
J Med Virol
|
2003
|
0.86
|
|
24
|
Variable-number tandem-repeat markers for typing Mycobacterium intracellulare strains isolated in humans.
|
BMC Microbiol
|
2010
|
0.85
|
|
25
|
Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort.
|
Curr HIV Res
|
2010
|
0.83
|
|
26
|
Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients.
|
Clin Infect Dis
|
2001
|
0.83
|
|
27
|
Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 Aquitaine Cohort.
|
J Acquir Immune Defic Syndr
|
2013
|
0.80
|
|
28
|
Avascular necrosis in HIV-infected patients: a case-control study from the Aquitaine Cohort, 1997-2002, France.
|
Clin Infect Dis
|
2005
|
0.80
|
|
29
|
Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.
|
J Acquir Immune Defic Syndr
|
2009
|
0.80
|
|
30
|
CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.
|
J Infect Dis
|
2002
|
0.78
|
|
31
|
Drug-drug interactions with systemic antifungals in clinical practice.
|
Pharmacoepidemiol Drug Saf
|
2007
|
0.77
|
|
32
|
HIV and HCV co-infection: situation at six French university hospitals in the year 2000.
|
J Med Virol
|
2003
|
0.76
|
|
33
|
Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus.
|
J Clin Microbiol
|
2006
|
0.76
|
|
34
|
Emergence of tularemia in the Landes area.
|
Int J Infect Dis
|
2012
|
0.75
|
|
35
|
Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management.
|
Nephron
|
2017
|
0.75
|
|
36
|
Serum ST2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aquitaine Cohort, France.
|
AIDS
|
2017
|
0.75
|
|
37
|
Prevalence of Mycoplasma genitalium among HIV-infected women, Agence Nationale de Recherches sur le SIDA et les hépatites virales CO3 Aquitaine Cohort, France.
|
Sex Transm Dis
|
2013
|
0.75
|
|
38
|
[Tuberculosis].
|
Rev Prat
|
2009
|
0.75
|
|
39
|
Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort.
|
J Clin Virol
|
2006
|
0.75
|
|
40
|
Prognostic factors of calcaneal osteomyelitis.
|
Scand J Infect Dis
|
2014
|
0.75
|
|
41
|
Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
|
AIDS
|
2017
|
0.75
|
|
42
|
Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients.
|
Clin Infect Dis
|
2003
|
0.75
|
|
43
|
Molecular characterization of non-B HIV type 1 isolates from patients of a department of infectious diseases, University Hospital of Bordeaux, France, 1989-2009.
|
AIDS Res Hum Retroviruses
|
2012
|
0.75
|
|
44
|
HIV-1 transmission during scintigraphy.
|
Lancet
|
2003
|
0.75
|
|
45
|
Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.
|
J Acquir Immune Defic Syndr
|
2008
|
0.75
|
|
46
|
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
|
J Acquir Immune Defic Syndr
|
2003
|
0.75
|
|
47
|
Characteristics of prosthetic joint infections leading to bacteremia: a case-control study.
|
Scand J Infect Dis
|
2013
|
0.75
|
|
48
|
Hyperprocalcitonemia due to mushroom poisoning.
|
Clin Infect Dis
|
2011
|
0.75
|
|
49
|
[Fascioliasis: a 23-year retrospective study].
|
Presse Med
|
2007
|
0.75
|
|
50
|
An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.
|
J Clin Virol
|
2006
|
0.75
|
|
51
|
Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1.
|
Antivir Ther
|
2002
|
0.75
|
|
52
|
CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007.
|
J Clin Virol
|
2010
|
0.75
|